BackgroundCheck.run
Search For

Paul R Mazanec, 4814321 Waconia St NE, Andover, MN 55304

Paul Mazanec Phones & Addresses

Andover, MN   

Isle, MN   

12219 Lincoln St, Minneapolis, MN 55434    763-8629158    763-7571929    763-8629157   

Blaine, MN   

Mankato, MN   

7600 Brigadoon Pl NE, Fridley, MN 55432   

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Mentions for Paul R Mazanec

Career records & work history

Medicine Doctors

Paul A. Mazanec

Specialties:
Gastroenterology, Hepatology
Work:
Gastroenterology Associates
317 Saint Francis Dr STE 170, Greenville, SC 29601
864-2327338 (phone) 864-4515180 (fax)
Site
Gastroenterology AssociatesGastroenterology Associates PA
200 Patewood Dr STE B200, Greenville, SC 29615
864-2327338 (phone) 864-4515180 (fax)
Site
Endoscopy Center Upstate
14 Hawthorne Park Ct, Greenville, SC 29615
864-3310364 (phone) 864-3310370 (fax)
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1985
Procedures:
Endoscopic Retrograde Cholangiopancreatography (ERCP), Esophageal Dilatation, Colonoscopy, Sigmoidoscopy, Upper Gastrointestinal Endoscopy, Vaccine Administration
Conditions:
Intestinal Obstruction, Abdominal Hernia, Abnormal Vaginal Bleeding, Acute Pancreatitis, Acute Pharyngitis, Acute Sinusitis, Alcohol Dependence, Anal Fissure, Anal or Rectal Abscess, Anemia, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Arterial Thromboembolic Disease, Atrial Fibrillation and Atrial Flutter, Benign Polyps of the Colon, Bronchial Asthma, Candidiasis, Cardiac Arrhythmia, Celiac Disease, Cholelethiasis or Cholecystitis, Chronic Fatigue Syndrome, Chronic Pancreatitis, Chronic Renal Disease, Cirrhosis, Constipation, Dermatitis, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Diverticulitis, Diverticulosis, Epilepsy, Esophagitis, Gastric Cancer, Gastritis and Duodenitis, Gastroesophageal Reflux Disease (GERD), Gastrointestinal Hemorrhage, Heart Failure, Hemorrhoids, Herpes Simplex, HIV Infection, Hypertension (HTN), Hypothyroidism, Infectious Liver Disease, Inflammatory Bowel Disease (IBD), Inguinal Hernia, Iron Deficiency Anemia, Irritable Bowel Syndrome (IBS), Ischemic Bowel Disease, Ischemic Heart Disease, Ischemic Stroke, Liver Cancer, Malignant Neoplasm of Colon, Malignant Neoplasm of Esophagus, Osteoporosis, Overweight and Obesity, Pancreatic Cancer, Parkinson's Disease, Peptic Ulcer Disease, Poisoning by Drugs, Meds, or Biological Substances, Pulmonary Tuberculosis (TB), Rectal, Abdomen, Small Intestines, or Colon Cancer, Rheumatoid Arthritis, Rosacea, Septicemia, Skin and Subcutaneous Infections, Substance Abuse and/or Dependency, Venous Embolism and Thrombosis, Ventral Hernia
Languages:
English, Spanish
Description:
Dr. Mazanec graduated from the Case Western Reserve University School of Medicine in 1985. He works in Greenville, SC and 2 other locations and specializes in Gastroenterology and Hepatology. Dr. Mazanec is affiliated with Bon Secours St Francis Downtown and Greenville Memorial Hospital.

Paul Mazanec resumes & CV records

Resumes

Paul Mazanec Photo 11

Chief Technology Officer And Vice President Research And Development

Location:
14321 Waconia St northeast, Andover, MN 55304
Industry:
Medical Devices
Work:
Medtronic Mar 2015 - Mar 2016
Senior Program Manager
Envoy Medical Mar 2015 - Mar 2016
Chief Technology Officer and Vice President Research and Development
Envoy Medical 2014 - Mar 2015
Vice President of Research and Development
Envoy Medical Apr 2011 - 2014
Director of Research and Development
Envoy Medical Feb 2008 - Apr 2011
Product Development Engineer and Manager
Medtronic Jan 2006 - Jun 2006
Senior Product Development Engineer
Lsi Corporation May 1999 - Jan 2006
Senior Analog Ic Design Engineer
Education:
University of Minnesota 2016
Doctorates, Doctor of Philosophy, Electrical Engineering, Philosophy
University of Minnesota 2013 - 2015
Master of Science, Masters, Electrical Engineering, Engineering
Spring Lake Park Senior High School
University of Minnesota Institute of Technology
Minnesota State University, Mankato
Bachelors, Bachelor of Science, Electrical Engineering
Skills:
Analog Circuit Design, Electro Mechanical Design, Integrated Circuit Design, Low Power Systems, Digital Signal Processors, Requirements Gathering, Regulatory Requirements, Innovation
Paul Mazanec Photo 12

Paul Mazanec

Location:
United States

Publications & IP owners

Us Patents

Fully-Implantable Microphoneless Cochlear Implant

US Patent:
2013001, Jan 17, 2013
Filed:
Jun 21, 2012
Appl. No.:
13/529011
Inventors:
Travis M. Beckerle - St. Paul MN, US
Joseph J. Halfen - Woodbury MN, US
Daniel E. Glumac - Lino Lakes MN, US
Paul R. Mazanec - Blaine MN, US
Daniel J. Nelson - Ramsev MN, US
Peter J. Schiller - Coon Rapids MN, US
Kevin E. Verzal - Lino Lakes MN, US
Brian P. Wallenfelt - Plymouth MN, US
International Classification:
H04R 25/00
US Classification:
600 25
Abstract:
A fully implantable apparatus for improving the hearing of a hearing-impaired subject is shown, said apparatus comprising a means for sensing vibrations impinging upon the tympanic membrane or an object in operative contact with the tympanic membrane, a means for converting said vibrations to an electrical signal, and a means for transmitting the electrical signal to the inner ear.

Feedback Scan For Hearing Aid

US Patent:
2013027, Oct 17, 2013
Filed:
Apr 11, 2012
Appl. No.:
13/444262
Inventors:
PAUL R. MAZANEC - Blaine MN, US
Assignee:
ENVOY MEDICAL CORPORATION - St. Paul MN
International Classification:
H04R 29/00
H04R 25/00
US Classification:
381 60
Abstract:
A hearing aid is disclosed, having the ability to generate its own open-loop feedback scan of amplitude (as gain or attenuation) and phase, as a function of frequency. The hearing aid has a sensor that receives ambient sound from near a patient, and a driver that stimulates the anatomy of the patient. The hearing aid has an operational mode in which the driver stimulates the anatomy of the patient in response to the sound received at the sensor. The hearing aid has a test mode in which a test frequency is stepped through a predetermined range of frequencies. At each test frequency, the driver is driven with a sinusoidal driver signal at the test frequency, the sensor detects a sinusoidal sensor signal at the test frequency, and a comparison of the sensor signal to the driver signal produces an amplitude (gain or attenuation) and a phase for the test frequency.

Transducer Impedance Measurement For Hearing Aid

US Patent:
2013027, Oct 17, 2013
Filed:
Apr 11, 2012
Appl. No.:
13/444368
Inventors:
PAUL R. MAZANEC - BLAINE MN, US
Assignee:
ENVOY MEDICAL CORPORATION - ST. PAUL MN
International Classification:
H04R 29/00
H04R 25/00
US Classification:
381 60
Abstract:
A hearing aid is disclosed, which, in a test mode, can determine the impedance of the transducer that stimulates the anatomy of the patient. Impedance may be determined by simultaneous determination of the current flowing through the transducer and the voltage across the transducer. In some cases, the output amplifier of the hearing aid includes two outputs, with one being a scaled and/or summed replica of the other. The amplifier is driven with a periodic signal with a particular frequency and a known peak voltage. The periodic signal may be sinusoidal. The primary output of the amplifier is electrically connected to the transducer, with a known voltage given by the peak input voltage and a known gain of the amplifier. The current from the secondary output of the amplifier is measured. In an example measurement scheme, the secondary output is sent through a rectifier and then through a low-pass filter.

Self-Regulating Transcutaneous Energy Transfer

US Patent:
2011004, Feb 24, 2011
Filed:
Aug 20, 2009
Appl. No.:
12/544367
Inventors:
Paul Richard Mazanec - Blaine MN, US
Assignee:
Envoy Medical Corporation - St. Paul MN
International Classification:
A61N 1/378
US Classification:
607 61
Abstract:
A rechargeable battery system and method are disclosed, in which an implantable medical device (IMD) regulates its transfer of energy from a separate charger unit. For recharging, a charger unit is brought into proximity to the implanted device. An oscillating current is generated in a primary coil, located in the charger. By inductive coupling through an oscillating magnetic field, an alternating current is generated in a secondary coil, which is implanted in or near the implanted device. The alternating current then passes through a half-wave or full-wave rectifier to form a one-sided current, then passes through a regulator to form an essentially direct current, which is in turn directed to the rechargeable battery in the implanted device. The secondary coil has a controllable damped resonant frequency, which can be dynamically tuned away from the driving frequency of the primary coil by a variable resistor and/or by varying a duty cycle of a rapidly switched electrical element. If a control loop in the implant senses that more power is being received at the second coil than is actually being used to recharge the battery, the control loop temporarily changes the variable resistance. When this happens, the resonant frequency of the secondary coil is detuned slightly away from the driving frequency, so that less of the incoming power is absorbed by the secondary coil. Alternatively, the secondary coil may be temporarily short-circuited. With less or no excess power entering the circuitry of the implant, the problem of overheating is mitigated.

Cochlear Implant System With Electrode Impedance Diagnostics

US Patent:
2022031, Oct 6, 2022
Filed:
Apr 5, 2021
Appl. No.:
17/222034
Inventors:
- White Bear Lake MN, US
Paul R. Mazanec - Ham Lake MN, US
International Classification:
A61N 1/36
A61N 1/05
A61N 1/372
Abstract:
Cochlear implant systems can comprise a cochlear implant system comprising a cochlear electrode, a stimulator in electrical communication with the cochlear electrode, a return electrode, and one or more controllers. The cochlear electrode can include a first contact electrode and the stimulator can include a first source element in electrical communication with the first contact electrode. The one or more controllers can be configured to cause the stimulator to emit a predetermined current from the first source element to the return electrode via a first current path and determine a first voltage at the first contact electrode and a second voltage at the return electrode. The one or more controllers can determine an impedance associated with the first current path and determine one or more stimulation parameters, such as a compliance voltage for sourcing a prescribed current, for the source element based on the determined impedance.

Combination Implant System With Removable Earplug Sensor And Implanted Battery

US Patent:
2022026, Aug 25, 2022
Filed:
Feb 23, 2021
Appl. No.:
17/182469
Inventors:
- White Bear Lake MN, US
Paul R. Mazanec - Ham Lake MN, US
International Classification:
A61N 1/05
A61N 1/378
A61N 1/36
Abstract:
Cochlear implant systems can comprise an implantable subsystem comprising a cochlear electrode, a stimulator, a battery, and a first near field communication interface positioned subcutaneously proximate an ear canal. Cochlear implant systems can further comprise a removable earplug comprising a sensor, a second near field communication interface, and a signal processor. The removable earplug can be inserted into an ear canal to align the first and second near field communication interfaces. Once aligned, the battery can provide electrical power to the removable earplug via the near field communication interfaces. The signal processor can receive input signals from the sensor of the removable earplug and generate a stimulation signal representative of the auditory signals. The signal processor can communicate the stimulation signal to the stimulator via the near field communication interfaces.

Cochlear Implant System With Integrated Signal Analysis Functionality

US Patent:
2022026, Aug 25, 2022
Filed:
Feb 23, 2021
Appl. No.:
17/182477
Inventors:
- White Bear Lake MN, US
Paul R. Mazanec - Ham Lake MN, US
International Classification:
A61N 1/372
H04R 25/00
A61N 1/05
A61N 1/36
A61N 1/378
Abstract:
A cochlear implant and analysis system includes a stimulator, an input source, a signal processor, a wireless communication interface, and an external device. The system can receive an acoustic stimulus, generate an input signal representative thereof, and apply a transfer function to the input signal to generate and output a stimulation signal to the stimulator. The signal processor can receive an analysis input indicating a first signal for analysis and generate an analysis signal based on the received analysis input. The first signal can be an input signal from an input source or a result of one or more processing steps. The signal processor can output the analysis signal to the wireless communication interface with the wireless communication interface configured to output a signal representative of the analysis signal to an external device.

Cochlear Implant Stimulation Calibration

US Patent:
2023000, Jan 5, 2023
Filed:
Sep 12, 2022
Appl. No.:
17/942710
Inventors:
- White Bear Lake MN, US
Paul R. Mazanec - Ham Lake MN, US
International Classification:
A61N 1/372
A61N 1/36
A61N 1/05
A61N 1/378
G01R 31/28
Abstract:
Cochlear implant systems can include a cochlear electrode and a stimulator in electrical communication with the cochlear electrode. The stimulator can be in communication with a controller, which is in communication with a testing circuit and a switching network. The stimulator can include a plurality of source elements. The controller can control the switching network to place the plurality of source elements into communication with the testing circuit. The controller can further cause one of the plurality of source elements to emit an electrical current and can determine an amount of electrical current emitted from the source element using the testing circuit. The controller can compare the determined amount of electrical current emitted by the source element with a prescribed current. The controller can adjust the output of each of the plurality of source elements based on the determined amount of electrical current emitted by the stimulator.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.